# Naveed Sattar

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/naveed-sattar/

## Facts

| Field | Value |
| --- | --- |
| Citations | 211,356 |
| Field | Diabetes Treatment and Management |
| h-index | 208 |
| i10-index | 1,237 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5078498803 |
| ORCID iD | 0000-0002-1604-2593 |
| Works | 2,146 |

## Researcher papers

Showing 12 of 39.

- [2016 European Guidelines on cardiovascular disease prevention in clinical practice](https://scholariq.org/papers/2016-european-guidelines-on-cardiovascular-disease-prevention-in-clinical/)
- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD](https://scholariq.org/papers/2019-esc-guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases/)
- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents](https://scholariq.org/papers/body-mass-index-and-all-cause-mortality-individual-participant-data-meta/)
- [Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials](https://scholariq.org/papers/statins-and-risk-of-incident-diabetes-a-collaborative-meta-analysis-of/)
- [Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial](https://scholariq.org/papers/primary-care-led-weight-management-for-remission-of-type-2-diabetes-direct-an/)
- [ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD](https://scholariq.org/papers/esc-guidelines-on-diabetes-pre-diabetes-and-cardiovascular-diseases-developed-in/)
- [Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials](https://scholariq.org/papers/cardiovascular-mortality-and-kidney-outcomes-with-glp-1-receptor-agonists-in/)
- [Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials](https://scholariq.org/papers/cardiovascular-mortality-and-kidney-outcomes-with-glp-1-receptor-agonists-in-2/)
- [Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study](https://scholariq.org/papers/metabolic-syndrome-with-and-without-c-reactive-protein-as-a-predictor-of/)
- [2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-cardiovascular-disease-in-patients/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.